Tomas Stopka

Title: Innovations by Tomas Stopka

Introduction

Tomas Stopka is an innovative inventor based in Dolní Břežany, Czech Republic. He has made significant contributions to the field of combination therapy for the treatment of hematological malignancies. His work focuses on the use of scientifically matched plant supplements combined with antineoplastic compounds.

Latest Patents

Tomas Stopka holds a patent titled "Use of scientifically matched plant supplements combined with antineoplastic compounds for the treatment of hematological malignancies." This patent relates to combination therapy for treating conditions such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). The disclosure provides a combination therapy that includes a therapeutically effective amount of plant-based compounds, such as sulforaphane, resveratrol, and curcumin, along with hypomethylating agents like azacitidine and decitabine. This combination aims to enhance the treatment efficacy while decreasing resistance to these agents.

Career Highlights

Throughout his career, Tomas Stopka has worked with notable companies, including Brio Ventures and Cannafamily a.s. His experience in these organizations has contributed to his expertise in the field of medical innovations.

Collaborations

Tomas has collaborated with professionals such as Shireen Vali and Taher Abbasi, further enriching his work and expanding the impact of his inventions.

Conclusion

Tomas Stopka's innovative approach to combining plant-based supplements with antineoplastic compounds represents a significant advancement in the treatment of hematological malignancies. His contributions to the field are noteworthy and continue to inspire further research and development.